Open access · US-GOV via ClinicalTrials.gov Clinical trial

Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients

Authors not listed

Abramson Cancer Center at Penn Medicine · 2023

Dysbiosis Exercise Human Randomized controlled trial

Abstract

This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT. The primary objective is to determine feasibility. Up to 60-72 evaluable subjects will be enrolled. Evaluable subjects are defined as those participating in the exercise intervention.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-21 MST

Cite this

APA

Anonymous. (2023). Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients. <em>Abramson Cancer Center at Penn Medicine</em>. https://clinicaltrials.gov/study/NCT05612789

Vancouver

Anonymous. Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients. Abramson Cancer Center at Penn Medicine. 2023.

BibTeX

@misc{anon2023Interv, title = {Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients}, author = {Anonymous}, journal = {Abramson Cancer Center at Penn Medicine}, year = {2023}, }